G256 HCl
CAS No. 134867-96-2
G256 HCl( —— )
Catalog No. M34516 CAS No. 134867-96-2
G256 HCl has antiarrhythmic and anti-ischemic activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 300 | Get Quote |
|
| 10MG | 445 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameG256 HCl
-
NoteResearch use only, not for human use.
-
Brief DescriptionG256 HCl has antiarrhythmic and anti-ischemic activity.
-
DescriptionG256 HCl has antiarrhythmic and anti-ischemic activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number134867-96-2
-
Formula Weight360.67
-
Molecular FormulaC14H16Cl3N5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN=C(N)N/N=C(C1=CC=CC=C1)\C2=C(C=CC(Cl)=C2)N.Cl.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Inclacumab
Inclacumab, a humanized monoclonal IgG4 antibody (Anti-Human Selectin P Recombinant Antibody), specifically binds to P-selectin with a dissociation constant (Kd) of 9.9 nM.
-
3,5-Di-O-caffeoylqui...
3,5-Di-O-caffeoylquinic acid methyl ester exhibits potent inhibitory activities against the formation of advanced glycation end products (AGEs); it exhibits cytotoxicity actions against human cervix carcinoma HeLa cells. 3,5-Di-O-caffeoylquinic acid methyl ester shows high efficiency and low toxicity with antivirus activity against RSV.
-
AM966
AM966, a excellent affinity, specific, oral LPA1(IC50=17 nM) antagonist, suppresses LPA-stimulated intracellular calcium release.
Cart
sales@molnova.com